Centessa Pharmaceuticals (CNTA) Other Non-Current Liabilities (2022 - 2025)
Historic Other Non-Current Liabilities for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $29000.0.
- Centessa Pharmaceuticals' Other Non-Current Liabilities changed 0.0% to $29000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $29000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $29000.0 for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Centessa Pharmaceuticals reported Other Non-Current Liabilities of $29000.0 as of Q3 2025, which was down 0.0% from $29000.0 recorded in Q2 2025.
- Centessa Pharmaceuticals' Other Non-Current Liabilities' 5-year high stood at $43000.0 during Q1 2022, with a 5-year trough of $29000.0 in Q4 2023.
- In the last 4 years, Centessa Pharmaceuticals' Other Non-Current Liabilities had a median value of $29000.0 in 2023 and averaged $32818.2.
- Within the past 5 years, the most significant YoY rise in Centessa Pharmaceuticals' Other Non-Current Liabilities was 0.0% (2024), while the steepest drop was 0.0% (2024).
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' Other Non-Current Liabilities stood at $43000.0 in 2022, then tumbled by 32.56% to $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024, then changed by 0.0% to $29000.0 in 2025.
- Its Other Non-Current Liabilities stands at $29000.0 for Q3 2025, versus $29000.0 for Q2 2025 and $29000.0 for Q1 2025.